Combining Neo-adjuvant ATR-inhibition With Nodal SBRT for Early-stage Resectable HPV+ OPSCCs

Clinical trial NCT07578467 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07578467
Sponsor: Abramson Cancer Center at Penn Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

HPV Positive Oropharyngeal Squamous Cell Carcinoma Squamous Cell Carcinoma HPV (Human Papillomavirus)-Associated Carcinoma HPV Associated Cancers Oropharyngeal HPV Squamous Cell Carcinoma

Start date: 2026-08-31
Primary completion: 2030-05-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.